TE_13200
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluJb |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | LTC4S |
| Class | Chimeric |
| Coding | Non-coding, Other |
| Tumor-specific score | 0.05 |
| Counts of samples | TCGA_tumor:43; TCGA_normal:5; GTEx:977 |
| TSS | chr5(+):179781036 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_13200.11 | LTC4S | Chimeric | Other | MQTLVSSLLAWPGSLALCGMVTPPCTPSTEMGRGEHRGCSSSPGPSSEQQTGLSVPQLAFTHSPCHHTDGTMKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQ* | chr5(+):179781037,179781084,179791764,179791866,179792163,179792346,179793874,179794138,179795584,179795856,179795941,179796022,179796253,179796273 |
| teRNA_13200.12 | LTC4S | Chimeric | Other | MQTLVSSLLAWPGSLALCGMVTPPCTPSTEMGRGEHRGCSSSPGPSSEQQTGLSVPQLAFTHSPCHHTDGTMKDEVALLAAVTLLGVLLQGDLGAQGLPRVAAAHHRPTRVRARLPSPGELQRVLPAVPRHALGRRHLLS* | chr5(+):179781037,179781084,179791764,179791866,179792163,179792346,179793874,179794138,179795601,179795683,179795786,179795856,179795941,179796022,179796253,179796273 |
| teRNA_13200.13 | LTC4S | Chimeric | Non-coding | Non-coding | chr5(+):179781037,179781084,179791764,179791866,179792163,179792346,179793874,179794138,179795584,179795683,179795786,179795856,179795941,179796022,179796253,179796273 |
| teRNA_13200.14 | LTC4S | Chimeric | Non-coding | Non-coding | chr5(+):179781037,179781084,179791764,179791866,179792163,179792346,179793874,179794138,179795941,179796022,179796253,179796273 |
| teRNA_13200.15 | LTC4S | Chimeric | Non-coding | Non-coding | chr5(+):179781037,179781084,179791764,179791866,179792163,179792346,179793874,179794138,179795584,179795604 |
| teRNA_13200.16 | LTC4S | Chimeric | Non-coding | Non-coding | chr5(+):179781037,179781084,179791764,179791866,179792163,179792346,179793874,179794138,179795584,179795683,179795786,179795856,179795941,179795961 |
| teRNA_13200.17 | LTC4S | Chimeric | Non-coding | Non-coding | chr5(+):179781037,179781084,179791764,179791866,179792151,179792346,179795584,179795856,179795941,179796022,179796253,179796273 |
| teRNA_13200.18 | LTC4S | Chimeric | Non-coding | Non-coding | chr5(+):179781037,179781084,179791764,179791866,179792151,179792346,179795584,179795683,179795786,179795856,179795941,179796022,179796253,179796273 |
| teRNA_13200.19 | LTC4S | Chimeric | Non-coding | Non-coding | chr5(+):179781037,179781084,179791764,179791866,179792151,179792346,179795584,179795604 |
| teRNA_13200.20 | LTC4S | Chimeric | Non-coding | Non-coding | chr5(+):179781037,179781084,179791764,179791866,179792151,179792346,179795584,179795683,179795786,179795856,179795941,179795961 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
